Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin 340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements - (Posted On Wednesday, July 07, 2021) 340B Update: Federal Court Halts 340B Administrative Dispute Resolution Rule - (Posted On Monday, March 29, 2021) Hospitals Ask Supreme Court to Reverse Site-Neutral, 340B Payment Rulings - (Posted On Thursday, March 25, 2021) 340B Drug Pricing Program 2021 Outlook [PODCAST] - (Posted On Friday, March 19, 2021) COVID-19: Reimbursement Corner: Graduate Medical Education Gets Major Boost From Congressional Appropriations Bill - (Posted On Wednesday, December 23, 2020) 340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions [PODCAST] - (Posted On Thursday, December 03, 2020) OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees - (Posted On Wednesday, December 02, 2020) 340B Update: Ryan White Clinics Sue in Response to Contract Pharmacy Actions as Congress Requests Information on Ways to Improve the 340B Program - (Posted On Friday, October 16, 2020) CMS'S Proposed Phase-Out of the Inpatient Only List is not Entirely Welcome News - (Posted On Tuesday, September 29, 2020) 340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions - (Posted On Saturday, September 26, 2020) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis Borrowing and Lending 101 by: Financial Poise Faculty Valuing Lost Profits in Litigation: Making the Case (and the Math) Work by: Financial Poise Faculty Practical Tips for Taking and Defending Depositions by: Michele Schechter AI Notetaking Tools Under Fire: Lessons from the Otter.ai Class Action Complaint by: Joseph J. Lazzarotti Why Anthropic’s Copyright Settlement Changes the Rules for AI Training by: Timothy P. Scanlan, Jr. , Andrew R. Lee The Future of Work: California Employment Legislation in 2025 by: Christopher W. Olmsted , Charles L. Thompson, IV Beltway Buzz, August 29, 2025 by: James J. Plunkett ECHA Publishes Updated REACH Restriction Proposal for PFAS by: Lynn L. Bergeson , Carla N. Hutton Colorado Budget Cuts Hit Home for Medicaid Providers by: Ryan B. Thurber , Bragg E. Hemme PEER Petitions MAHA Commission to Remove PFAS from U.S. Food Chain by: Lynn L. Bergeson , Carla N. Hutton Canada’s Plan of Priorities Includes Several Nanoscale Materials by: Lynn L. Bergeson , Carla N. Hutton Age Discrimination Act—Which Proscribes Age Discrimination in Programs Receiving Federal Assistance—Does Not Apply to Medical Residency Rankings, Ninth Circuit Panel Rules by: Daniel J. Ganz European Court of Justice Ruling on Works Agreements: Reinforcing GDPR Compliance in the Workplace by: Simon J. McMenemy , Benjamin W. Perry The Empire State's Continuing Battle Over the Timing of Local Elections by: Joseph T. Burns Some Congressional Dissent to Trump Administration’s AI Chip Sales to China; FTC Cracks Down on AI Marketing Claims — AI: The Washington Report by: Bruce D. Sokler , Alexander Hecht Upcoming Events Sep 15-16 2025 Chief Litigation Officer Summit Sep 15-16 2025 US General Counsel Summit Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Oct 20-21 2025 Intellectual Property Law Institute 2025 - California Print
